Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...
Take-Two is closing two game studios under their Private Division label, with Kerbal Space Program 2 developer Intercept Games shutting down (as we already knew) and OlliOlli and Rollerdrome studio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results